Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and  Forecast, 2015 – 2021

Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Forecast, 2015 – 2021

Comments Off on Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Forecast, 2015 – 2021

According to the report, the global injectable drug discovery market was valued at approximately USD 328.20 million in 2015 and is expected to reach approximately USD 640.50 million by 2021, growing at a CAGR of around 11.8% between 2016 and 2021.Injectable drug delivery plays an important role in pharmacotherapy due to its rapid onset of action. Several drugs, predominantly peptides, pharmaceutical agents, protein and other therapeutics agents, can only be administered by injectable routes. The parenteral administration route is one of the most common and efficient drug delivery forms.



According to the report, the global injectable drug discovery market was valued at approximately USD 328.20 million in 2015 and is expected to reach approximately USD 640.50 million by 2021, growing at a CAGR of around 11.8% between 2016 and 2021.

Administration of a drug or drugs directly into patient’s blood circulation through a delivery device is called as injectable drug delivery. Some predominant peptides, pharmaceutical agents, protein and other therapeutics agents can be administered by injectable routes. The parentral administration route is one of the most common and efficient drug delivery forms.

The global injectable drug delivery market is expected to witness substantial growth in the years to come. The market is mainly driven by rapid growth in population coupled with increasing incidences of chronic diseases like cancer and diabetes. Moreover, the innovations in technological processes have resulted in the development of advanced devices. Additionally, technological advancement like dual-injectables has further enhanced the process of drug delivery performed by injectables. Thus, these noteworthy changes are expected to propel the growth of the market within the forecast period. However, healthcare awareness regarding infections and injuries caused by the needles used in syringes may hamper the market growth within the forecast period. Nevertheless, the rise in demand for biosimilars and generic injectables is expected to open up new growth avenues in the near future.

Global Injectable Drug Delivery Market

Device and formulation are the key types in the global injectable drug delivery market. The formulation is further segmented into conventional drug delivery, novel drug delivery, and others. Formulation segment held the largest market share of total revenue generated in 2015. This growth is mainly driven by benefits such as reduced side effects and high efficacy offered by formulations. The devices segment is bifurcated into conventional injection devices and self-injection devices. Self-injection devices include of needle-free injectors, auto-injectors, pen-injectors, and others. The device includes self-injection devices which are expected to be the fastest growing segment in the near future.

Based on end-user, injectable drug delivery market can be segmented into hospitals, homecare, and others. Homecare accounted for the largest market share due to increasing incidences of diabetes diseases. The increasing prevalence of diabetes worldwide has allowed the key participant in this market to launch advanced devices for the administration of insulin with the help of self-injection device. Thus, homecare segment is expected to witness exponential growth within the forecast period.

North America was the largest regional market for injectable drug delivery in 2015 due to increasing scientific research and development of novel technologies. Moreover, high investment of the U.S. private companies in biology R&D activities is further expected to boost the injectable drug delivery market in this region. Europe was another leading regional market due to the high demand of self-injection devices coupled with increasing penetration of companies in R&D activities in biotechnology perspective. Asia Pacific is expected to exhibit strong growth for injectable drug delivery in the years to come. This growth is mainly due to rapid growth in population coupled with increasing the prevalence of chronic disease, especially in India and China.

Some of the key players in the global injectable drug delivery market include Pfizer, Inc., Baxter International, Inc., Terumo Corporation, Becton, Dickinson and Company, Schott AG among others

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global injectable drug delivery market, 2015 – 2021 USD Billion)
    • 2.2. Global injectable drug delivery market : Snapshot
  • Chapter 3. Injectable Drug Delivery – Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global injectable drug delivery market drivers: Impact analysis
      • 3.2.2. Increasing aging population
    • 3.3. Market restraints
      • 3.3.1. Global injectable drug delivery market restraints: Impact analysis
      • 3.3.2. Possibility of needle infection and injuries
    • 3.4. Opportunities
      • 3.4.1. Increasing demand generic injactable
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type segment
      • 3.6.2. Market attractiveness analysis, by end-user segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Injectable Drug Delivery Market – Competitive Landscape
    • 4.1. Company market share, 2015 (Subject To Data Availability)
      • 4.1.1. Global injectable drug delivery market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Type and Regional Expansion
    • 4.3. Product Portfolio
  • Chapter 5. Global Injectable Drug Delivery Market – Type Analysis
    • 5.1. Global injectable drug delivery market: Type overview
      • 5.1.1. Global injectable drug delivery market revenue share, by type, 2015 – 2021
    • 5.2. Device
      • 5.2.1. Global injectable drug delivery market for device, 2015 – 2021 (USD Billion)
      • 5.2.2. Conventional Injection Devices
        • 5.2.2.1. Global injectable drug delivery market for conventional injection devices, 2015 – 2021 (USD Billion)
      • 5.2.3. Self-Injection Devices
        • 5.2.3.1. Global injectable drug delivery market for self-injection devices, 2015 – 2021 (USD Billion)
    • 5.3. Formulations
      • 5.3.1. Global injectable drug delivery market for formulations, 2015 – 2021 (USD Billion)
      • 5.3.2. Conventional Drug Delivery
        • 5.3.2.1. Global injectable drug delivery market for conventional injection devices, 2015 – 2021 (USD Billion)
      • 5.3.3. Novel Drug Delivery
        • 5.3.3.1. Global injectable drug delivery market for novel drug delivery, 2015 – 2021 (USD Billion)
      • 5.3.4. Others
        • 5.3.4.1. Global injectable drug delivery market for other, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Injectable Drug Delivery Market – End-User Analysis
    • 6.1. Global injectable drug delivery market: End-user overview
      • 6.1.1. Global injectable drug delivery market revenue share, by end-user, 2015 – 2021
    • 6.2. Hospitals
      • 6.2.1. Global injectable drug delivery market for hospitals, 2015 – 2021 (USD Billion)
    • 6.3. Homecare
      • 6.3.1. Global injectable drug delivery market for homecare, 2015 – 2021 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global injectable drug delivery market for others, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Injectable Drug Delivery Market – Regional Segment Analysis
    • 7.1. Global injectable drug delivery market: Regional overview
      • 7.1.1. Global injectable drug delivery market revenue share, by region, 2015 – 2021
    • 7.2. North America
      • 7.2.1. North America injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.2.2. North America injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.2.3.2. U.S. injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.3.2. Europe injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany injectable drug delivery market revenue, by type, 2015 – 2021, (USD Billion)
        • 7.3.3.2. Germany injectable drug delivery market revenue, by end-user, 2015 – 2021, (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France injectable drug delivery market revenue, by type, 2015 – 2021, (USD Billion)
        • 7.3.4.2. France injectable drug delivery market revenue, by end-user, 2015 – 2021, (USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.3.5.2. UK injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific injectable drug delivery market revenue, by type, 2015 – 2021, (USD Billion)
      • 7.4.2. Asia Pacific injectable drug delivery market revenue, by end-user, 2015 – 2021, (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.3.2. China injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.4.2. Japan injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.4.5.2. India injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.5.2. Latin America injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
        • 7.5.3.2. Brazil injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa injectable drug delivery market revenue, by type, 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East and Africa injectable drug delivery market revenue, by end-user, 2015 – 2021 (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Pfizer, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Baxter International Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Terumo Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Becton, Dickinson and Company
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Schott AG
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Sandoz
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Gerresheimer AG
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Baxter International, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Alkermes PLC
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy

List of Figures 
1. Market research process
2. Market research methodology
3. Global injectable drug delivery market revenue, 2015 – 2021(USD Billion)
4. Porter’s five forces analysis
5. Injectable drug delivery : Market attractiveness analysis, by type segment
6. Injectable drug delivery: Market attractiveness analysis, by end-user segment
7. Injectable drug delivery: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015
9. Global injectable drug delivery market revenue share by type, 2015 – 2021
10. Global  injectable drug delivery market for device, 2015 – 2021, (USD Billion)
11. Global  injectable drug delivery market for formulations, 2015 – 2021, (USD Billion)
12. Global injectable drug delivery market revenue share by end-user, 2015 – 2021
13. Global  injectable drug delivery market hospitals, 2015 – 2021, (USD Billion)
14. Global  injectable drug delivery market for homecare, 2015 – 2021, (USD Billion)
15. Global injectable drug delivery market for  others, 2015 – 2021, (USD Billion)


List of Tables

1. Injectable drug delivery  market: Market snapshot
2. Drivers of global injectable drug delivery  market: Impact analysis
3. Restraints of global injectable drug delivery  market: Impact analysis
4. North America injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
5. North America injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
6. U.S. injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
7. U.S. injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
8. Germany injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
9. Germany injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
10. France injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
11. France injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
12. UK injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
13. UK injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
14. Asia Pacific injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
15. Asia Pacific injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
16. China injectable drug delivery market revenue, by type 2015 – 2021(USD Billion)
17. China injectable drug delivery market revenue, by end-user 2015 – 2021(USD Billion)
18. Japan injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
19. Japan injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
20. India injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
21. India injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
22. Latin America injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
23. Latin America injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
24. Brazil injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
25. Brazil injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)
26. Middle East and Africa injectable drug delivery market revenue, by type, 2015 – 2021(USD Billion)
27. Middle East and Africa injectable drug delivery market revenue, by end-user, 2015 – 2021(USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account